On follow-up visits, will there be perverse incentives on the doctors to throw a lot of medications at the problem since it is tied to the doctor's reimbursement? Keep in mind the data is made public so the quality and outcome measures will affect all future patient referrals without the ability of the doctor to explain the complexity of each person's individual medical challenges or socioeconomic factors tied to his particular public outcome data.